Publication: Prevalence of cervical cytological abnormalities in Turkey
| dc.contributor.authors | Kara, Fadil; Kiran, Guerkan; Metindir, Jale; Ozan, Hakan; Ozalp, Sinan; Vardar, M. Ali; Zeren, Handan; Dilek, Saffet; Bozkaya, Hasan; Guven, Sueleyman; Ersoz, Safak; Acikalm, Arbil; Meydanli, Mutlu; Cetinarslan, Ilknur; Gokaslan, Huesnu; Eren, Funda; Celik, Cetin; Yilmaz, Osman; Celik, Huesnue; Aksaz, Zeliha; Kocak, Cengiz; Bagci, Hafize; Davutoglu, Bilge Sel; Hakverdi, Ali Ulvi; Soysal, Mehmet Emin; Kaya, Guelcan; Yanik, Ali; Arici, Sema; Cetin, Halit; Mutlu, Ahmet Emin; Kolusari, Ali; Kosem, Mustafa; Sahin, Guler; Demirturk, Fazli; Gultekin, Murat; Karaca, Mehmet; Harma, Mehmet; Harma, Muege; Batur, Sebnem; Demirbag, Nilgun; Baykal, Cem; Dogan, Isin; Sam, Asli Demir | |
| dc.date.accessioned | 2022-03-12T17:47:05Z | |
| dc.date.accessioned | 2026-01-11T15:17:22Z | |
| dc.date.available | 2022-03-12T17:47:05Z | |
| dc.date.issued | 2009 | |
| dc.description.abstract | Objective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.ijgo.2009.04.003 | |
| dc.identifier.eissn | 1879-3479 | |
| dc.identifier.issn | 0020-7292 | |
| dc.identifier.pubmed | 19541303 | |
| dc.identifier.uri | https://hdl.handle.net/11424/229662 | |
| dc.identifier.wos | WOS:000269782800005 | |
| dc.language.iso | eng | |
| dc.publisher | WILEY | |
| dc.relation.ispartof | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Cervical cancer | |
| dc.subject | Cervical cytology | |
| dc.subject | Cervical intraepithelial neoplasias | |
| dc.subject | Cervical neoplasias | |
| dc.subject | Pap test | |
| dc.subject | Pap smear | |
| dc.subject | Turkey | |
| dc.subject | CERVICOVAGINAL CYTOLOGY | |
| dc.subject | COMPARISON PROGRAM | |
| dc.subject | PARTICIPANTS | |
| dc.subject | CANCER | |
| dc.subject | WOMEN | |
| dc.subject | RISK | |
| dc.title | Prevalence of cervical cytological abnormalities in Turkey | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 209 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | 206 | |
| oaire.citation.title | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | |
| oaire.citation.volume | 106 |
